Lavipharm S.A. filed its Annual on Mar 21, 2022 for the period ending Dec 31, 2021. In this report its auditor, Grant Thornton, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.852 EUR | -0.93% | +0.59% | +7.04% |
1st Jan change | Capi. | |
---|---|---|
+7.04% | 154M | |
+20.81% | 43.34B | |
+20.44% | 21.96B | |
+11.60% | 14.09B | |
+12.97% | 13.64B | |
+39.74% | 11.43B | |
-8.59% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.22B |
- Stock Market
- Equities
- LAVI Stock
- News Lavipharm S.A.
- Lavipharm S.A. Auditor Raises 'Going Concern' Doubt